Making sense of the newest Section 337 developments will be a key focus of The American Conference Institute’s 13th Annual Practitioners’ Think Tank on ITC Litigation and Enforcement.
- Navigating patent eligibility in digital healthcare 22-06-2021
- The curious case of Wuhan’s Institute of Virology and remdesivir 20-04-2021
- EPO’s new examination guidelines: what you need to know 06-04-2021
- The uncertain future of antibody claims 01-04-2021
- The doctrine of equivalents in the medtech arena 18-11-2020
Latest biotechnology news
Bio-Rad Laboratories has settled its long-running dispute with 10X Genomics over patents covering genetic analysis tech and both companies have negotiated an agreement to cross-license their products.